Ligand validation:5WIN

SKE: 4-({5-amino-1-[(2,6-difluorophenyl)carbonyl]-1H-1,2,4-triazol-3-yl}amino)benzenesulfonamide

SKE is a Ligand Of Interest in 5WIN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WIN_SKE_A_901	66%	3%	0.135	0.941	2.62	3.62	12	12	0	0	100%	1
8B99_SKE_A_1003	79%	2%	0.098	0.942	4.29	2.74	23	15	2	0	100%	1
5USZ_SKE_A_901	73%	8%	0.111	0.939	2.1	2.53	7	10	1	0	100%	1
5USY_SKE_A_1201	94%	9%	0.07	0.968	1.91	2.5	7	7	0	0	100%	1
3AMA_SKE_A_351	85%	21%	0.087	0.952	1.87	1.47	5	4	0	0	100%	1
5DT0_SKE_A_401	79%	12%	0.118	0.964	1.91	2.12	1	7	0	0	100%	1
5DR9_SKE_A_401	76%	10%	0.132	0.969	2.09	2.27	7	10	1	0	100%	1
6DRW_SKE_A_1201	74%	8%	0.127	0.957	2.18	2.51	7	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.